Trademark: 97301062
Status Date
Tuesday, February 20, 2024
Filing Date
Tuesday, March 8, 2022
Published for Opposition
Tuesday, August 2, 2022
5 pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for the treatment of metastatic tumors and lesions; Pharmaceuticals, namely, for destroying, inhibiting or preventing the spread of uncontrolled growth of abnormal tissues, namely, metastatic tumors and lesions
Feb 21, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 20, 2024
Sou Extension 3 Granted
Feb 20, 2024
Sou Extension 3 Filed
Feb 20, 2024
Sou Teas Extension Received
Nov 7, 2023
Assigned To Examiner
Sep 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 14, 2023
Sou Extension 2 Granted
Sep 14, 2023
Sou Extension 2 Filed
Sep 14, 2023
Sou Teas Extension Received
Mar 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 13, 2023
Sou Extension 1 Granted
Mar 13, 2023
Sou Extension 1 Filed
Mar 13, 2023
Sou Teas Extension Received
Sep 27, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 2, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 2, 2022
Published For Opposition
Jul 13, 2022
Notification Of Notice Of Publication E-Mailed
Jun 30, 2022
Approved For Pub - Principal Register
Jun 30, 2022
Assigned To Examiner
Mar 14, 2022
New Application Office Supplied Data Entered
Mar 11, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24